Stay updated on Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.

Latest updates to the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page
- Check6 days agoChange DetectedThe page now includes an additional topic tag for 'Multiple myeloma' and a related topic link to 'MedlinePlus Genetics'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedLocations section updated with new regions (Arizona, Colorado, Michigan, New York, Ohio, Oregon, Texas, Wisconsin, New South Wales, South Australia, Tasmania, Victoria, Western Australia, Rio Grande do Sul, Alberta) and removal of the previous 'Locations' subheadings; Revision: v3.3.3 tag added.SummaryDifference0.8%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedAdded mentions of Multiple Myeloma and related topics (MedlinePlus Genetics) and the revision note 'Revision: v3.3.2'. The PubMed publications boilerplate was revised with a note 'Revision: v3.2.0'.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page no longer displays the government funding/status notice banner at the top.SummaryDifference0.2%

- Check71 days agoChange DetectedThe page no longer shows the topic 'Multiple Myeloma' and omits the related topic 'MedlinePlus Genetics'. This reduces the disease-focused context and keyword associations used for discovery.SummaryDifference0.3%

- Check78 days agoChange DetectedRemoved MedlinePlus Genetics topic on multiple myeloma (a core medical topic).SummaryDifference0.1%

Stay in the know with updates to Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.